Aier Eye Hospital Group Co., Ltd. (SHE:300015)

China flag China · Delayed Price · Currency is CNY
12.55
+0.03 (0.24%)
Oct 17, 2025, 3:06 PM CST
0.24%
Market Cap116.66B
Revenue (ttm)21.94B
Net Income (ttm)3.56B
Shares Out9.30B
EPS (ttm)0.38
PE Ratio32.66
Forward PE29.03
Dividend0.16 (1.27%)
Ex-Dividend DateJun 11, 2025
Volume88,003,133
Average Volume79,958,890
Open12.77
Previous Close12.52
Day's Range12.37 - 12.77
52-Week Range11.77 - 17.36
Beta0.67
RSI46.73
Earnings DateOct 24, 2025

About Aier Eye Hospital Group

Aier Eye Hospital Group Co., Ltd. operates as a ophthalmology chain medical company in China, Hong Kong, Europe, the United States, and Southeast Asia. The company offers diagnosis and treatment of various ophthalmic diseases, surgical services, medical optometry, and glasses for fundus diseases, refractive correction, glaucoma, corneal diseases, and cataract. It also provides training course for cataract prevention and treatment. Aier Eye Hospital Group Co., Ltd. was founded in 2002 and is headquartered in Changsha, China. [Read more]

Sector Healthcare
Founded 2002
Employees 42,693
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300015
Full Company Profile

Financial Performance

In 2024, Aier Eye Hospital Group's revenue was 20.98 billion, an increase of 3.02% compared to the previous year's 20.37 billion. Earnings were 3.56 billion, an increase of 5.87%.

Financial Statements

News

There is no news available yet.